Hypersensitivity to follitropin alfa or to any of the excipients.
Tumours of the hypothalamus and pituitary gland.
Ovarian enlargement or ovarian cyst not due to polycystic ovarian syndrome.
Gynaecological haemorrhages of unknown aetiology.
Ovarian, uterine or mammary carcinoma.
FOLISAN (r-hFSH) should not be used when an effective response cannot be obtained, such as: Primary ovarian failure; Malformations of sexual organs incompatible with pregnancy; Fibroid tumours of the uterus incompatible with pregnancy.